Evidence map›Paper›PMID 35695521›Full record

ArticleJournal of visualized experiments : JoVE2022

A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment.

Brian M Burkel, David R Inman, María Virumbrales-Muñoz, Erica J Hoffmann, Suzanne M Ponik

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancer.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brian M BurkelDepartment of Cell and Regenerative Biology, University of Wisconsin-Madison.
David R InmanDepartment of Cell and Regenerative Biology, University of Wisconsin-Madison.
María Virumbrales-MuñozDepartment of Cell and Regenerative Biology, University of Wisconsin-Madison; Department of Pathology, University of Wisconsin-Madison.
Erica J HoffmannDepartment of Cell and Regenerative Biology, University of Wisconsin-Madison.
Suzanne M PonikDepartment of Cell and Regenerative Biology, University of Wisconsin-Madison; Carbone Cancer Center, University of Wisconsin-Madison; ponik@wisc.edu.

Funding

TECH CoreU54CA268069 · NCI · UNIVERSITY OF MINNESOTA · PI David J. Odde · 2022 to 2026
$8.2M
Matrix density promotes pro-tumorigenic hormone actions in breast cancerR01CA179556 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI PONIK, SUZANNE MARIE, SCHULER, LINDA A. · 2014 to 2024
$4.9M
Exosome secretion in breast cancer progressionR01CA206458 · NCI · VANDERBILT UNIVERSITY · PI PONIK, SUZANNE MARIE, WEAVER, ALISSA M · 2016 to 2025
$4.6M
(7) Novel imaging devices for measurement and control of tumor microenvironmentsR01CA216248 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CADY, NATHANIEL CHARLES, CONDEELIS, JOHN S · 2017 to 2021
$2.9M
Direct therapeutic intervention of the tumor microenvironment with a potent inhibitor of fibronectin assemblyR21CA252579 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KWON, GLEN S., PONIK, SUZANNE MARIE · 2021 to 2022
$386k
NCI NIH HHS R01 CA179556NCI NIH HHS R01 CA206458NCI NIH HHS R01 CA216248NCI NIH HHS R21 CA252579NCI NIH HHS U54 CA268069
6 · The paper itself

Abstract

The ability to visualize complex and dynamic physiological interactions between numerous cell types and the extracellular matrix (ECM) within a live tumor microenvironment is an important step toward understanding mechanisms that regulate tumor progression. While this can be accomplished through current intravital imaging techniques, it remains challenging due to the heterogeneous nature of tissues and the need for spatial context within the experimental observation. To this end, we have developed an intravital imaging workflow that pairs collagen second harmonic generation imaging, endogenous fluorescence from the metabolic co-factor NAD(P)H, and fluorescence lifetime imaging microscopy (FLIM) as a means to non-invasively compartmentalize the tumor microenvironment into basic domains of the tumor nest, the surrounding stroma or ECM, and the vasculature. This non-invasive protocol details the step-by-step process ranging from the acquisition of time-lapse images of mammary tumor models to post-processing analysis and image segmentation. The primary advantage of this workflow is that it exploits metabolic signatures to contextualize the dynamically changing live tumor microenvironment without the use of exogenous fluorescent labels, making it advantageous for human patient-derived xenograft (PDX) models and future clinical use where extrinsic fluorophores are not readily applicable.

Indexed as

Mammary Neoplasms, AnimalTumor MicroenvironmentAnimalsExtracellular MatrixHumansIntravital MicroscopyMicroscopy, Fluorescence

Identifiers

PMID35695521
PMCPMC9327791

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.